Provenienza dei contatti di primo grado di Sandra Ramos-Alves
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Biotechnology | 22 | |
22
| Subsidiary | Pharmaceuticals: Major | 22 |
21
| Subsidiary | Pharmaceuticals: Major | 21 |
| Public Company | Biotechnology | 19 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sandra Ramos-Alves tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Compliance Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Compliance Officer | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chairman Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Tal Medical, Inc.
 Tal Medical, Inc. Medical SpecialtiesHealth Technology Tal Medical, Inc. operates as a clinical stage medical device company. It develops novel, non contact, neuromodulatory devices for the treatment of psychiatric and neurological disorders. The firm focuses on the development of LFMS for the treatment of major depressive disorder and bipolar depression. The company was founded by Daphne Zohar, Steven Marc Paul, Andrew Miller, Eric Elenko and Nessan Bermingham in 2010 and is headquartered in Boston, MA. | Medical Specialties | Founder Chief Tech/Sci/R&D Officer Founder | |
| University of Virginia | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| Emory University | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
| University of South Carolina | College/University | Doctorate Degree Masters Business Admin | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member General Counsel | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Executive Officer Chief Operating Officer | |
| ALLERGAN PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Chief Operating Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
American College of Neuropsychopharmacology
 American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PURETECH HEALTH PLC | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| METACRINE, INC. | Biotechnology | Director/Board Member Founder Chief Executive Officer Chief Operating Officer | |
| OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
| VAXART, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
| ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Y-MABS THERAPEUTICS, INC. | Director/Board Member Chairman | ||
| TURNSTONE BIOLOGICS CORP. | Biotechnology | Director/Board Member Human Resources Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 48 |
| Regno Unito | 2 |
| Irlanda | 2 |
Settori
| Health Technology | 29 |
| Consumer Services | 13 |
| Finance | 5 |
| Commercial Services | 5 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 400 |
| Independent Dir/Board Member | 174 |
| Corporate Officer/Principal | 159 |
| Chairman | 67 |
| Undergraduate Degree | 63 |
Contatti più connessi
| Insiders | |
|---|---|
| James Healy | 50 |
| Carol Gallagher | 39 |
| Steven Paul | 38 |
| Richard Heyman | 33 |
| Julie Cherrington | 32 |
| Clarence Machado | 29 |
| Maha Katabi | 28 |
| Faheem Hasnain | 27 |
| Bruce Carter | 25 |
| Christopher Coughlin | 23 |
| Simeon George | 23 |
| Jeff Jonas | 21 |
| David Wheadon | 21 |
| Mark Alles | 20 |
| Atul Pande | 20 |
- Borsa valori
- Insiders
- Sandra Ramos-Alves
- Connessioni Società
